Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 7
Submit an article Journal homepage
3,843
Views
62
CrossRef citations to date
0
Altmetric
Brief Report

K27M-mutant histone-3 as a novel target for glioma immunotherapy

Katharina OchsDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
,
Martina OttDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
,
Theresa BunseDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Neurology, University Hospital Mannheim, Mannheim, Germany
,
Felix SahmDepartment of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
,
Lukas BunseDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
,
Katrin DeumelandtDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
,
Jana K. SonnerDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, GermanyORCID Iconhttp://orcid.org/0000-0002-4700-272X
ORCID Icon,
Melanie KeilDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
,
Andreas von DeimlingDepartment of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
,
Wolfgang WickDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
&
Michael PlattenDepartment of Neurology, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany;DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Neurology, University Hospital Mannheim, Mannheim, Germany;Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, GermanyCorrespondence[email protected]
 show all
Article: e1328340 | Received 10 Apr 2017, Accepted 05 May 2017, Published online: 05 Jul 2017

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Julian S. Rechberger, Samantha M. Bouchal, Erica A. Power, Leo F. Nonnenbroich, Cody L. Nesvick & David J. Daniels. (2023) Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies. Expert Opinion on Therapeutic Targets 27:11, pages 1071-1086.
Read now
Joshua D. Bernstock, Samantha E. Hoffman, Ari D. Kappel, Pablo A. Valdes, Walid Ibn Essayed, Neil V. Klinger, Kyung-Don Kang, Stacie K. Totsch, Hannah E. Olsen, Charles W. Schlappi, Katharina Filipski, Florian A. Gessler, Lissa Baird, Mariella G. Filbin, Rintaro Hashizume, Oren J. Becher & Gregory K. Friedman. (2022) Immunotherapy approaches for the treatment of diffuse midline gliomas. OncoImmunology 11:1.
Read now
James Felker & Alberto Broniscer. (2020) Improving long-term survival in diffuse intrinsic pontine glioma. Expert Review of Neurotherapeutics 20:7, pages 647-658.
Read now

Articles from other publishers (59)

Chantel Cacciotti & Karen D. Wright. (2023) Advances in Treatment of Diffuse Midline Gliomas. Current Neurology and Neuroscience Reports.
Crossref
Niklas Grassl, Katharina Sahm, Heike Süße, Isabel Poschke, Lukas Bunse, Theresa Bunse, Tamara Boschert, Iris Mildenberger, Anne-Kathleen Rupp, Max Philipp Ewinger, Lisa-Marie Lanz, Monika Denk, Ghazaleh Tabatabai, Michael W. Ronellenfitsch, Ulrich Herrlinger, Martin Glas, Dietmar Krex, Peter Vajkoczy, Antje Wick, Inga Harting, Felix Sahm, Andreas von Deimling, Martin Bendszus, Wolfgang Wick & Michael Platten. (2023) INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas. Neurological Research and Practice 5:1.
Crossref
Niklas Grassl, Isabel Poschke, Katharina Lindner, Lukas Bunse, Iris Mildenberger, Tamara Boschert, Kristine Jähne, Edward W. Green, Ingrid Hülsmeyer, Simone Jünger, Tobias Kessler, Abigail K. Suwala, Philipp Eisele, Michael O. Breckwoldt, Peter Vajkoczy, Oliver M. Grauer, Ulrich Herrlinger, Joerg-Christian Tonn, Monika Denk, Felix Sahm, Martin Bendszus, Andreas von Deimling, Frank Winkler, Wolfgang Wick, Michael Platten & Katharina Sahm. (2023) A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nature Medicine 29:10, pages 2586-2592.
Crossref
Stacie S. Wang, Kirti Pandey, Katherine A. Watson, Rebecca C. Abbott, Nicole A. Mifsud, Fiona M. Gracey, Sri H. Ramarathinam, Ryan S. Cross, Anthony W. Purcell & Misty R. Jenkins. (2023) Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma. Molecular Therapy - Oncolytics 30, pages 167-180.
Crossref
Alessio Ardizzone, Rossella Basilotta, Alessia Filippone, Lelio Crupi, Marika Lanza, Sofia Paola Lombardo, Cristina Colarossi, Dorotea Sciacca, Salvatore Cuzzocrea, Emanuela Esposito & Michela Campolo. (2023) Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. Cells 12:6, pages 841.
Crossref
Lena Immisch, George Papafotiou, Oliver Popp, Philipp Mertins, Thomas Blankenstein & Gerald Willimsky. (2023) Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al . Journal for ImmunoTherapy of Cancer 11:3, pages e006784.
Crossref
Zinal S Chheda, Sabine Mueller, Bindu Hegde, Akane Yamamichi, Lisa H Butterfield & Hideho Okada. (2023) Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al . Journal for ImmunoTherapy of Cancer 11:3, pages e006617.
Crossref
Yujia Chen, Chao Zhao, Shenglun Li, Jun Wang & Hongwei Zhang. (2023) Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma. Cancers 15:3, pages 602.
Crossref
Cecilia Dalle Ore, Christina Coleman, Nalin Gupta & Sabine Mueller. (2023) Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas. Pediatric Neurosurgery 58:5, pages 259-266.
Crossref
Dagoberto Estevez-Ordonez, Sam E. Gary, Travis J. Atchley, Pedram D. Maleknia, Jordan A. George, Nicholas M.B. Laskay, Evan G. Gross, Rishi K. Devulapalli & James M. Johnston. (2023) Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions. Pediatric Neurosurgery 58:5, pages 313-336.
Crossref
Ashley L. B. Raghu, Jason A. Chen, Pablo A. Valdes, Walid Ibn Essayed, Elizabeth Claus, Omar Arnaout, Timothy R. Smith, E. Antonio Chiocca, Pier Paolo Peruzzi & Joshua D. Bernstock. (2022) Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature. Cancers 15:1, pages 174.
Crossref
Payal Aggarwal, Wen Luo, Katherine C. Pehlivan, Hai Hoang, Prajwal Rajappa, Timothy P. Cripe, Kevin A. Cassady, Dean A. Lee & Mitchell S. Cairo. (2022) Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations. Frontiers in Immunology 13.
Crossref
Lukas Bunse, Theresa Bunse, Christopher Krämer, Yu-Chan Chih & Michael Platten. (2022) Clinical and Translational Advances in Glioma Immunotherapy. Neurotherapeutics 19:6, pages 1799-1817.
Crossref
Guohao Liu, Yanmei Qiu, Po Zhang, Zirong Chen, Sui Chen, Weida Huang, Baofeng Wang, Xingjiang Yu & Dongsheng Guo. (2022) Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies. Pharmaceutics 14:9, pages 1762.
Crossref
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Stefania Bartolini & Alba Ariela Brandes. (2022) Tumor-Associated Microenvironment of Adult Gliomas: A Review. Frontiers in Oncology 12.
Crossref
Da-Biao Deng, Yu-Ting Liao, Jiang-Fen Zhou, Li-Na Cheng, Peng He, Sheng-Nan Wu, Wen-Sheng Wang & Quan Zhou. (2022) Non-Invasive Prediction of Survival Time of Midline Glioma Patients Using Machine Learning on Multiparametric MRI Radiomics Features. Frontiers in Neurology 13.
Crossref
Jean-Paul Bryant, Victor M. Lu, Vaidya Govindarajan, Roberto J. Perez-Roman & Allan D. Levi. (2022) Immunotherapeutic treatments for spinal and peripheral nerve tumors: a primer. Neurosurgical Focus 52:2, pages E8.
Crossref
Eugene I. Hwang, Elias J. Sayour, Catherine T. Flores, Gerald Grant, Robert Wechsler-Reya, Lan B. Hoang-Minh, Mark W. Kieran, Joanne Salcido, Robert M. Prins, John W. Figg, Michael Platten, Kate M. Candelario, Paul G. Hale, Jason E. Blatt, Lance S. Governale, Hideho Okada, Duane A. Mitchell & Ian F. Pollack. (2022) The current landscape of immunotherapy for pediatric brain tumors. Nature Cancer 3:1, pages 11-24.
Crossref
Michael Kilian, Mirco Friedrich, Khwab Sanghvi, Edward Green, Stefan Pusch, Daisuke Kawauchi, Martin Löwer, Jana K. Sonner, Christopher Krämer, Julia Zaman, Stefanie Jung, Michael O. Breckwoldt, Gerald Willimsky, Stefan B. Eichmüller, Andreas von Deimling, Wolfgang Wick, Felix Sahm, Michael Platten & Lukas Bunse. (2022) T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas. Clinical Cancer Research 28:2, pages 378-389.
Crossref
Kevin Hai-Ning Lu, Julius Michel, Michael Kilian, Katrin Aslan, Hao Qi, Niklas Kehl, Stefanie Jung, Khwab Sanghvi, Katharina Lindner, Xin-Wen Zhang, Edward W Green, Isabel Poschke, Miriam Ratliff, Theresa Bunse, Felix Sahm, Andreas von Deimling, Wolfgang Wick, Michael Platten & Lukas Bunse. (2022) T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells. Neuro-Oncology Advances 4:1.
Crossref
Daniela Mancarella & Christoph Plass. (2021) Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation. Genome Medicine 13:1.
Crossref
Michael Kilian, Theresa Bunse, Wolfgang Wick, Michael Platten & Lukas Bunse. (2021) Genetically Modified Cellular Therapies for Malignant Gliomas. International Journal of Molecular Sciences 22:23, pages 12810.
Crossref
Fabrício Guimarães Gonçalves, Angela N. Viaene & Arastoo Vossough. (2021) Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas. Frontiers in Neurology 12.
Crossref
Hannah V. Chatwin, Joselyn Cruz Cruz & Adam L. Green. (2021) Pediatric high‐grade glioma: moving toward subtype‐specific multimodal therapy. The FEBS Journal 288:21, pages 6127-6141.
Crossref
James L Ross, Jose Velazquez Vega, Ashley Plant, Tobey J MacDonald, Oren J Becher & Dolores Hambardzumyan. (2021) Tumour immune landscape of paediatric high-grade gliomas. Brain 144:9, pages 2594-2609.
Crossref
Zhenjie Yi, Lifu Long, Yu Zeng & Zhixiong Liu. (2021) Current Advances and Challenges in Radiomics of Brain Tumors. Frontiers in Oncology 11.
Crossref
Peter Hauser. (2021) Classification and Treatment of Pediatric Gliomas in the Molecular Era. Children 8:9, pages 739.
Crossref
Justin Lee, Benjamin R. Uy & Linda M. Liau. (2021) Brain Tumor Vaccines. Neurosurgery Clinics of North America 32:2, pages 225-234.
Crossref
Jens Blobner, Michael Kilian, Chin Leng Tan, Katrin Aslan, Khwab Sanghvi, Jochen Meyer, Manuel Fischer, Kristine Jähne, Michael O Breckwoldt, Felix Sahm, Andreas von Deimling, Martin Bendszus, Wolfgang Wick, Michael Platten, Edward Green & Lukas Bunse. (2021) Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neuro-Oncology Advances 3:1.
Crossref
Hannah E Olsen, Geoffrey M Lynn, Pablo A Valdes, Christian D Cerecedo Lopez, Andrew S Ishizuka, Omar Arnaout, W Linda Bi, Pier Paolo Peruzzi, E Antonio Chiocca, Gregory K Friedman & Joshua D Bernstock. (2021) Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies. Neuro-Oncology Advances 3:1.
Crossref
Takahide Nejo, Abigail Mende & Hideho Okada. (2020) The current state of immunotherapy for primary and secondary brain tumors: similarities and differences. Japanese Journal of Clinical Oncology 50:11, pages 1231-1245.
Crossref
Maya S. Graham & Ingo K. Mellinghoff. (2020) Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy. International Journal of Molecular Sciences 21:19, pages 7193.
Crossref
Elizabeth S. Duke & Roger J. Packer. (2020) Update on Pediatric Brain Tumors: the Molecular Era and Neuro-immunologic Beginnings. Current Neurology and Neuroscience Reports 20:8.
Crossref
Jacob S. Young, Andrew J. Gogos, Ramin A. Morshed, Shawn L. Hervey-Jumper & Mitchel S. Berger. (2020) Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know. Acta Neurochirurgica 162:8, pages 1929-1939.
Crossref
Naveen K. Mehta, Roma V. Pradhan, Ava P. Soleimany, Kelly D. Moynihan, Adrienne M. Rothschilds, Noor Momin, Kavya Rakhra, Jordi Mata-Fink, Sangeeta N. Bhatia, K. Dane Wittrup & Darrell J. Irvine. (2020) Pharmacokinetic tuning of protein–antigen fusions enhances the immunogenicity of T-cell vaccines. Nature Biomedical Engineering 4:6, pages 636-648.
Crossref
Elizabeth A. Finch, Elizabeth Duke, Eugene I. Hwang & Roger J. Packer. (2020) Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity. Pediatric Neurology 107, pages 7-15.
Crossref
Stefaan Van Gool, Jennifer Makalowski, Erin Bonner, Oliver Feyen, Matthias Domogalla, Lothar Prix, Volker Schirrmacher, Javad Nazarian & Wilfried Stuecker. (2020) Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines 7:5, pages 29.
Crossref
Takahide Nejo, Akane Yamamichi, Neil D. Almeida, Yitzhar E. Goretsky & Hideho Okada. (2020) Tumor antigens in glioma. Seminars in Immunology 47, pages 101385.
Crossref
Johannes Gojo, Zdenek Pavelka, Danica Zapletalova, Maria T. Schmook, Lisa Mayr, Sibylle Madlener, Michal Kyr, Klara Vejmelkova, Martin Smrcka, Thomas Czech, Christian Dorfer, Jarmila Skotakova, Amedeo A. Azizi, Monika Chocholous, Dominik Reisinger, David Lastovicka, Dalibor Valik, Christine Haberler, Andreas Peyrl, Hana Noskova, Karol Pál, Marta Jezova, Renata Veselska, Sarka Kozakova, Ondrej Slaby, Irene Slavc & Jaroslav Sterba. (2020) Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities. Frontiers in Oncology 9.
Crossref
I. V. Chekhonin, G. L. Kobyakov & O. I. Gurina. (2020) Dendritic cell vaccines in neurological oncology. Voprosy neirokhirurgii imeni N.N. Burdenko 84:1, pages 76.
Crossref
Razina Aziz-Bose & Michelle Monje. (2019) Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets. Current Opinion in Oncology 31:6, pages 522-530.
Crossref
Valérie Dutoit, Denis Migliorini & Pierre-Yves Dietrich. (2019) Current strategies for vaccination in glioblastoma. Current Opinion in Oncology 31:6, pages 514-521.
Crossref
Ryan J. Duchatel, Evangeline R. Jackson, Frank Alvaro, Brett Nixon, Hubert Hondermarck & Matthew D. Dun. (2019) Signal Transduction in Diffuse Intrinsic Pontine Glioma. PROTEOMICS 19:21-22.
Crossref
Bas Weenink, Kaspar Draaisma, Han Z. Ooi, Johan M. Kros, Peter A. E. Sillevis Smitt, Reno Debets & Pim J. French. (2019) Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens. Scientific Reports 9:1.
Crossref
Jessica B Foster, Peter J Madsen, Meenakshi Hegde, Nabil Ahmed, Kristina A Cole, John M Maris, Adam C Resnick, Phillip B Storm & Angela J Waanders. (2019) Immunotherapy for pediatric brain tumors: past and present. Neuro-Oncology 21:10, pages 1226-1238.
Crossref
Xiaorui Su, Ni Chen, Huaiqiang Sun, Yanhui Liu, Xibiao Yang, Weina Wang, Simin Zhang, Qiaoyue Tan, Jingkai Su, Qiyong Gong & Qiang Yue. (2019) Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain. Neuro-Oncology.
Crossref
Pin He, Wei Chen, Xi Xiong Qiu, Yi Bin Xi, Hong Guan & Jun Xia. (2019) A Rare High-Grade Glioma with a Histone H3 K27M Mutation in the Hypothalamus of an Adult Patient. World Neurosurgery 128, pages 527-531.
Crossref
Bas Weenink, Mandy van Brakel, Rebecca Wijers, Peter A. E. Sillevis Smitt, Pim J. French & Reno Debets. (2019) Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients. Journal of Neuro-Oncology 144:1, pages 79-87.
Crossref
Nicole A P Lieberman, Kole DeGolier, Heather M Kovar, Amira Davis, Virginia Hoglund, Jeffrey Stevens, Conrad Winter, Gail Deutsch, Scott N Furlan, Nicholas A Vitanza, Sarah E S Leary & Courtney A Crane. (2019) Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro-Oncology 21:1, pages 83-94.
Crossref
Eshini Panditharatna, Lindsay B. Kilburn, Mariam S. Aboian, Madhuri Kambhampati, Heather Gordish-Dressman, Suresh N. Magge, Nalin Gupta, John S. Myseros, Eugene I. Hwang, Cassie Kline, John R. Crawford, Katherine E. Warren, Soonmee Cha, Winnie S. Liang, Michael E. Berens, Roger J. Packer, Adam C. Resnick, Michael Prados, Sabine Mueller & Javad Nazarian. (2018) Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clinical Cancer Research 24:23, pages 5850-5859.
Crossref
Wolfgang Wick & Michael Platten. (2018) Understanding and Treating Glioblastoma. Neurologic Clinics 36:3, pages 485-499.
Crossref
K. Ochs, L. Bunse, I. Mildenberger, W. Wick & M. Platten. (2018) Immuntherapien bei GliomenGlioma immunotherapy. best practice onkologie 13:4, pages 196-204.
Crossref
Michael Platten, Lukas Bunse, Dennis Riehl, Theresa Bunse, Katharina Ochs & Wolfgang Wick. (2018) Vaccine Strategies in Gliomas. Current Treatment Options in Neurology 20:5.
Crossref
Jorge Scutti. (2018) Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review). International Journal of Oncology.
Crossref
Zinal S. Chheda, Gary Kohanbash, Kaori Okada, Naznin Jahan, John Sidney, Matteo Pecoraro, Xinbo Yang, Diego A. Carrera, Kira M. Downey, Shruti Shrivastav, Shuming Liu, Yi Lin, Chetana Lagisetti, Pavlina Chuntova, Payal B. Watchmaker, Sabine Mueller, Ian F. Pollack, Raja Rajalingam, Angel M. Carcaboso, Matthias Mann, Alessandro Sette, K. Christopher Garcia, Yafei Hou & Hideho Okada. (2018) Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. Journal of Experimental Medicine 215:1, pages 141-157.
Crossref
Hideaki ABE, Manabu NATSUMEDA, Yu KANEMARU, Jun WATANABE, Yoshihiro TSUKAMOTO, Masayasu OKADA, Junichi YOSHIMURA, Makoto OISHI & Yukihiko FUJII. (2018) MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas. Neurologia medico-chirurgica 58:7, pages 290-295.
Crossref
Wolfgang Wick, Matthias Osswald, Antje Wick & Frank Winkler. (2018) Treatment of glioblastoma in adults. Therapeutic Advances in Neurological Disorders 11, pages 175628641879045.
Crossref
Thomas C. Wirth & Florian Kühnel. (2017) Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?. Frontiers in Immunology 8.
Crossref
Katharina Ochs, Lukas Bunse, Iris Mildenberger, Wolfgang Wick & Michael Platten. (2017) Immuntherapien bei GliomenGlioma immunotherapy. Der Onkologe 23:10, pages 831-837.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.